FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2148785799> ?p ?o ?g. }

• W2148785799 endingPage "609" @default.
• W2148785799 startingPage "605" @default.
• W2148785799 abstract "The unique clinical role of endoscopic retrograde cholangiopancreatography (ERCP) in diagnosing and treating biliary tree diseases cannot be completely replaced by other modern imaging modalities such as magnetic resonance cholangiopancreatography. However, post-ERCP pancreatitis is one of the most common and life-threatening complications. Prophylactic medication in the prevention of pancreatitis during ERCP is still controversial. The objective of the present study was to investigate the role of different regimens of somatostatin in the prevention of acute pancreatitis after ERCP and analyze the risk factors contributing to post-ERCP complications.From July 1999 to September 2000, 133 patients with benign biliary disease who received ERCP for diagnosis or treatment were enrolled. Group A patients received a bolus of somatostatin infusion before ERCP, followed by continuous infusion for 12 hours. Group B patients received a bolus of somatostatin before ERCP only, and group C patients were the controls who did not receive somatostatin treatment. Serum amylase levels before and 24 hours after ERCP, and abdominal pain were recorded.There were no significant differences in bile duct and pancreatic duct visualization, ratio of diagnostic and therapeutic ERCP, procedure time, post-procedural hyperamylasemia and pancreatitis among the 3 groups. For patients with visualization of the pancreatic duct, the incidences of hyperamylasemia (serum amylase > or = 220 U/L) were higher than in patients without visualization of the pancreatic duct (p < 0.001). All 6 patients with post-ERCP pancreatitis had pancreatic duct visualization, and recovered after conservative treatment.Continuous infusion of somatostatin after ERCP does not seem to be helpful in the prevention of pancreatic complications after ERCP. Pancreatic duct visualization is a risk factor for pancreatic complications." @default.
• W2148785799 created "2016-06-24" @default.
• W2148785799 creator A5006428879 @default.
• W2148785799 creator A5012607482 @default.
• W2148785799 creator A5016877762 @default.
• W2148785799 creator A5049268798 @default.
• W2148785799 creator A5053601305 @default.
• W2148785799 creator A5071784319 @default.
• W2148785799 creator A5077314509 @default.
• W2148785799 creator A5091075952 @default.
• W2148785799 date "2008-12-01" @default.
• W2148785799 modified "2023-10-17" @default.
• W2148785799 title "Effect of Somatostatin in the Prevention of Pancreatic Complications After Endoscopic Retrograde Cholangiopancreatography" @default.
• W2148785799 cites W1561812037 @default.
• W2148785799 cites W1967410704 @default.
• W2148785799 cites W1969993577 @default.
• W2148785799 cites W1972747259 @default.
• W2148785799 cites W1978020576 @default.
• W2148785799 cites W1999490350 @default.
• W2148785799 cites W2000273814 @default.
• W2148785799 cites W2005984088 @default.
• W2148785799 cites W2019862200 @default.
• W2148785799 cites W2043813971 @default.
• W2148785799 cites W2046376983 @default.
• W2148785799 cites W2055220713 @default.
• W2148785799 cites W2062905044 @default.
• W2148785799 cites W2070786747 @default.
• W2148785799 cites W2125091092 @default.
• W2148785799 cites W2136102866 @default.
• W2148785799 cites W2152273073 @default.
• W2148785799 cites W2156198880 @default.
• W2148785799 cites W2161408096 @default.
• W2148785799 cites W2316926039 @default.
• W2148785799 cites W2320210611 @default.
• W2148785799 doi "https://doi.org/10.1016/s1726-4901(09)70002-4" @default.
• W2148785799 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/19114324" @default.
• W2148785799 hasPublicationYear "2008" @default.
• W2148785799 type Work @default.
• W2148785799 sameAs 2148785799 @default.
• W2148785799 citedByCount "14" @default.
• W2148785799 countsByYear W21487857992013 @default.
• W2148785799 countsByYear W21487857992015 @default.
• W2148785799 countsByYear W21487857992016 @default.
• W2148785799 countsByYear W21487857992017 @default.
• W2148785799 countsByYear W21487857992018 @default.
• W2148785799 countsByYear W21487857992019 @default.
• W2148785799 countsByYear W21487857992021 @default.
• W2148785799 countsByYear W21487857992023 @default.
• W2148785799 crossrefType "journal-article" @default.
• W2148785799 hasAuthorship W2148785799A5006428879 @default.
• W2148785799 hasAuthorship W2148785799A5012607482 @default.
• W2148785799 hasAuthorship W2148785799A5016877762 @default.
• W2148785799 hasAuthorship W2148785799A5049268798 @default.
• W2148785799 hasAuthorship W2148785799A5053601305 @default.
• W2148785799 hasAuthorship W2148785799A5071784319 @default.
• W2148785799 hasAuthorship W2148785799A5077314509 @default.
• W2148785799 hasAuthorship W2148785799A5091075952 @default.
• W2148785799 hasBestOaLocation W21487857991 @default.
• W2148785799 hasConcept C126322002 @default.
• W2148785799 hasConcept C170835558 @default.
• W2148785799 hasConcept C181199279 @default.
• W2148785799 hasConcept C185592680 @default.
• W2148785799 hasConcept C2775967933 @default.
• W2148785799 hasConcept C2776297358 @default.
• W2148785799 hasConcept C2776474662 @default.
• W2148785799 hasConcept C2776670229 @default.
• W2148785799 hasConcept C2778444009 @default.
• W2148785799 hasConcept C2778865844 @default.
• W2148785799 hasConcept C2779960720 @default.
• W2148785799 hasConcept C2780892919 @default.
• W2148785799 hasConcept C2909698591 @default.
• W2148785799 hasConcept C55493867 @default.
• W2148785799 hasConcept C71924100 @default.
• W2148785799 hasConcept C90924648 @default.
• W2148785799 hasConceptScore W2148785799C126322002 @default.
• W2148785799 hasConceptScore W2148785799C170835558 @default.
• W2148785799 hasConceptScore W2148785799C181199279 @default.
• W2148785799 hasConceptScore W2148785799C185592680 @default.
• W2148785799 hasConceptScore W2148785799C2775967933 @default.
• W2148785799 hasConceptScore W2148785799C2776297358 @default.
• W2148785799 hasConceptScore W2148785799C2776474662 @default.
• W2148785799 hasConceptScore W2148785799C2776670229 @default.
• W2148785799 hasConceptScore W2148785799C2778444009 @default.
• W2148785799 hasConceptScore W2148785799C2778865844 @default.
• W2148785799 hasConceptScore W2148785799C2779960720 @default.
• W2148785799 hasConceptScore W2148785799C2780892919 @default.
• W2148785799 hasConceptScore W2148785799C2909698591 @default.
• W2148785799 hasConceptScore W2148785799C55493867 @default.
• W2148785799 hasConceptScore W2148785799C71924100 @default.
• W2148785799 hasConceptScore W2148785799C90924648 @default.
• W2148785799 hasIssue "12" @default.
• W2148785799 hasLocation W21487857991 @default.
• W2148785799 hasLocation W21487857992 @default.
• W2148785799 hasOpenAccess W2148785799 @default.
• W2148785799 hasPrimaryLocation W21487857991 @default.
• W2148785799 hasRelatedWork W1577057172 @default.
• W2148785799 hasRelatedWork W2046276733 @default.
• W2148785799 hasRelatedWork W2062908287 @default.

• next